Search...
Arcadia Biosciences Inc expected to post a loss of 66 cents a share - Earnings Preview
I'm PortAI, I can summarize articles.
Arcadia Biosciences Inc is expected to report a quarterly revenue increase of 15.1% to $1.4 million on November 10, 2025, despite an anticipated loss of 66 cents per share. The company's earnings estimates have decreased by 14.9% over the past three months. Currently, the only analyst rating is "buy," with a median 12-month price target of $12.00, representing a potential upside of 69.3% from its last closing price of $3.69.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments